Eric Rougemond

EUSA Pharma SAS specializes in pharmaceutical research for rare diseases. The company was founded by Gilles Alberici on September 24, 1999 and is headquartered in Limonest, France.

PX Therapeutics SA manufactures and develops recombinant proteins and monoclonal antibodies. Its services include protein engineering, optimization of drug candidates, humanization of antibodies, and production and release of GMP batches for clinical studies. The firm specializes in the field of in-vivo and in-vitro diagnostics, industrial enzymes, and ancillary products. The company was founded by Tristan Rousselle and Nicolas Mouz in November 2000 and is headquartered in Grenoble, France.

Laboratoire Aguettant SAS manufactures pharmaceutical products. It offers emergency medicines, micronutrition, Parkinson and pre-filled syringes. The company was founded by Georges Aguettant in 1941 and is headquartered in Lyon, France.

Part of Aguettant Sante SA, Aguettant Ltd. is a British company that manufactures hospital medicines. The company is based in Bristol, UK. The company was founded in 2004. The CEO is Eric Rougemond.

Aguettant Sante SA manufactures and commercializes pharmaceutical products. The company was founded in 1954 and is headquartered in Lyon, France.

Part of Aguettant Sante SA, Promise Proteomics SAS is a French biotechnology company. The company is based in Grenoble, France. The company was founded in 2010. Eric Rougemond has been the CEO of the company since 2019.